Detailed View
PCRX - Pacira BioSciences, Inc.
Latest filing: 2026-06-30 | Reporting: gaap
Market Cap
1,452,405,760
Adj EBIT (TTM)
29,806,500
Enterprise Value
1,564,498,760
Last Price
36.39
Earnings Yield
1.91%
Return on Capital
3.65%
Capital
816,841,000
1Y Price Chart
Last Price: $36.39
1Y Change: 70.60%
As of 2026-10-29 | 1Y Change: 70.60%
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-06-30 | 10-Q | 2026 | 192,399,000 | 4,267,000 |
| 2026-03-31 | 10-Q | 2026 | 177,376,000 | 6,902,000 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 196,873,000 | 2,340,000 |
| 2025-09-30 | 10-Q | 2025 | 179,516,000 | 6,362,000 |
| 2025-06-30 | 10-Q | 2025 | 181,099,000 | 8,499,000 |
| 2025-03-31 | 10-Q | 2025 | 168,923,000 | 1,990,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | -513,713,000 | 24,704,000 |
| 2024-09-30 | 10-Q | 2024 | 168,573,000 | 36,272,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.